Collective Growth Files for a $150M Cannabis SPAC
by Kristi Marvin on 2020-03-02 at 1:19pm

This morning, Collective Growth Corp. (CGROU), filed for a new $150 million SPAC focused on the Cannabinoid sector.  This team will be led by Bruce Linton, as Chairman and CEO, having previously founded and served as Chairman and CEO of Canopy Growth (NYSE: CGC), a diversified cannabis, hemp and cannabis device company. Additionally, Mr. Linton will be joined by Geoffrey Whaling, as President, Tim Saunders, as CFO, and Wilson Kello, as Chief Marketing Officer, all having recently worked for Canopy Growth (or adjacent to Canopy Growth, in Mr. Kello’s case) as well. So while this SPAC is named “Collective Growth”, it’s a little bit like “Canopy Growth II”.

However, it should be noted that Mr. Linton was asked to step down as CEO and Board Member of Canopy Growth last June. If you recall, the cannabis sector came under significant pressure starting late last spring/early summer, and it seems the board of Canopy Growth wasn’t willing to give Mr. Linton time to grow his company.  Make of that what you will, but there’s no denying that he does have a significant amount of cannabis company experience.  And public cannabis company experience to boot.  Put it this way….he knows the good, the bad and the ugly.

Additionally, while this SPAC will be looking in the cannabis space, it is specifically looking at cannabinoids, which are the chemicals derived from cannabis (CBD oil comes to mind). Cannabinoids that have been developed and taken from hemp plants are legal and can be found in many markets. However, Cannabinoids derived from Marijuana plants are only legal in some states.  However, the prospectus does say that Collective Growth intends to focus on the “Federally permissible cannabinoid industry”.  However, even if this team finds a company in the non-permissable category, they can probably just re-list in Canada.  Although, it would have been interesting to see an upfront dual Nasdaq/Neo (Canada) listing such as what Merdia Merger Corp. I did, to take advantage of both target universes.

As for this SPAC’s structure, it will be a 24 month, 100% in trust 1/2 warrant IPO, with a Crescent Term threshold of $9.20.  Standard stuff.  But again, we already have six SPACs out currently searching for targets within the cannabis sector.  Collective Growth will be the seventh. Plus, three of those six SPACs are $150 million in size, which is the same size as Collective Growth, with a fourth SPAC at $120 million.  That’s a lot of fish trying to feed in the same pond.  What investors would really like to see is an ANNOUNCED cannabis deal.  And if it’s a good one, the cannabis IPOs become a far easier sell.

Since while this SPAC does have a “cannabis brand-name” team, there’s still a little bit of noise surrounding the deal.  That could be compounded by the current market conditions, but it will be a good SPAC to use as a litmus test to see how it performs in a market that has been shut to traditional IPOs.  To clarify, the 1/4 warrant deals shouldn’t be affected in this market, but it’s the SPACs below that tier that we will want to watch and see how they do to gauge where the larger SPAC market is headed.

Summary of terms below:

Collective Growth Summary of terms

 

Recent Posts
by Nicholas Alan Clayton on 2024-03-27 at 1:31pm

News and Rumors CNBC: Former WeWork (OTC Pink:WEWKQ) founder Adam Neumann has offered to buy back control of the company for $500 million but has yet to secure the necessary financing. WeWork went public with BowX in October 2021. PR: Satellite telecom firm Spire Global (NYSE:SPIR) has signed an agreement to build and launch two...

by Nicholas Alan Clayton on 2024-03-27 at 11:38am

Bannix (NASDAQ:BNIX) has entered into a definitive agreement to combine with VisionWave Technologies for $30 million. The combined company is expected to trade on the Nasdaq once the deal is completed with an initial outside date of September 14. Transaction Overview Bannix has about $17 million in its trust after seeing 77.4% of its shares...

by Nicholas Alan Clayton on 2024-03-27 at 7:33am

At the SPAC of Dawn Much of the attention yesterday was on tracking the swings of the newly-completed Trump Media (NASDAQ:DJT) deal with the FT going as far to suggest it may “make SPACs great again.” Not all of the day’s data points were on the positive side of the ledger, however. IB Acquisition Corp....

by Nicholas Alan Clayton on 2024-03-26 at 1:52pm

News and Rumors SpaceNews: Boeing (NYSE:BA) has sued Virgin Galactic (NASDAQ:SPCE) alleging the space tourism venture refused to pay $25 million it owed for design work and violated Boeing’s intellectual property rights. Virgin Galactic combined with Social Capital Hedosophia in 2019. Bloomberg: The most popular options contract for Trump Media (NASDAQ:DJT) predicts it to plunge...

by Nicholas Alan Clayton on 2024-03-26 at 11:51am

APx (NASDAQ:APXI) has entered into a definitive agreement to combine with precision medicine firms OmnigenicsAI and MultiplAI at an enterprise value $340 million. Once combined, these companies will offer DNA tests to consumers linked to predictive insights on their nutritional and genomic health. The combined company is expected to trade on the Nasdaq under the...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved